A Randomized, Open-label, Multiple-dose and Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A in Male Subjects
Latest Information Update: 25 Jan 2024
At a glance
- Drugs CKD-843 (Primary)
- Indications Alopecia
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
Most Recent Events
- 18 Jan 2024 Status changed from not yet recruiting to completed.
- 25 Oct 2022 New trial record